Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BBOT compared with ANL: revenue, margins and what each company keeps, and the suppliers and customers both name
BBOT
BridgeBio Oncology Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ANL
Adlai Nortye Ltd.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BBOT
BridgeBio Oncology Therapeutics, Inc.
vs
ANL
Adlai Nortye Ltd.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
BBOT
1 of 4 reports
Report
implied
realized
× implied
Q2 FY26
—
▲
+2.39%
—
ANL
No earnings history for ANL.
= implied
BBOT realized, solid
ANL realized, hatched
One scale, both sides: full bar = 3%
× = |realized| ÷ implied
Source: market data
BBOT
BridgeBio Oncology Therapeutics, Inc.
Change
2.02
▼
−6.83%
· post 2.08
Mkt cap
$163.3M
ANL
Adlai Nortye Ltd.
Change
10.28
▲
+6.17%
· post 10.28
Closed
Nov 6 '26
Mkt cap
$986.1M
vs
Compare
Closed
Nov 6 '26
BBOT
BridgeBio Oncology Therapeutics, Inc.
vs
ANL
Adlai Nortye Ltd.
2.02
▼
−6.83%
post 2.08
Price
10.28
▲
+6.17%
post 10.28
$163.3M
Mkt cap
$986.1M
Change
Change
BBOT
2.02
▼
−6.83%
vs
ANL
10.28
▲
+6.17%
Closed
Nov 6 '26